1.A Case of Thymic Cyst in the Middle Mediastinum Mimicking Pericardial Cyst.
Sung Il IM ; Sung Ji PARK ; Jin Shin KHO ; Jeong Hee LEE ; Bong Ryong CHOI ; Jong Woo KIM ; Choong Hwan KWAK ; Jin Yong HWANG
Journal of Cardiovascular Ultrasound 2007;15(2):40-42
A thymic cyst in the middle mediastinum adjacent to the right pericardium is extremely rare. We report a case of a large thymic cyst in the right cardiophrenic angle, compressing the right atrium, which was presented as a cardiomegaly on the chest radiograph and a pericardial cyst on the echocardiography. The definitive diagnosis was confirmed using surgical resection and biopsy.
Biopsy
;
Cardiomegaly
;
Diagnosis
;
Echocardiography
;
Heart Atria
;
Magnetic Resonance Imaging
;
Mediastinal Cyst*
;
Mediastinum*
;
Pericardium
;
Radiography, Thoracic
2.High Transcript Level of FLT3 Associated with High Risk of Relapse in Pediatric Acute Myeloid Leukemia.
Hyoung Jin KANG ; Ji Won LEE ; Sang Hyeok KHO ; Min Jeong KIM ; Young Jin SEO ; Hyery KIM ; Hee Young SHIN ; Hyo Seop AHN
Journal of Korean Medical Science 2010;25(6):841-845
Identification of prognostic factors and risk-based post-remission therapy was proposed to improve the outcomes of acute myeloid leukemia (AML) and a mutation of FLT3 has been reported to be a risk factor, especially for pediatric patients. Recently, FLT3 expression level was implicated to have prognostic significance in adults, but little is known for childhood AML. To define the prognostic significance, transcript level of FLT3 was analyzed in 52 pediatric AML patients. The median copy number of FLT3 was 4.6x10(3) (40-5.9x10(7) copies)/1.0x10(6) GAPDH copy, and the relapse free survival of patients with high transcript level of FLT3 (>10(6) copy number) (0%) was significantly lower than that of the others (53.2%). High transcript level of FLT3 was associated with a markedly high risk of relapse. The development of new therapeutic scheme such as a frontline allogeneic stem cell transplantation or administration of FLT3 inhibitor is needed to improve outcomes.
3.Effective Timing of Introducing an Inpatient Smoking Cessation Program to Cancer Patients
Yu-Ri CHOE ; Ji-Won CHOI ; Ju-Ri JEONG ; Hye-Mi DOH ; Mi-Lee KIM ; Min-Seol NAM ; Hee-Ji KHO ; Ha-Young PARK ; Hye-Ran AHN ; Sun-Seog KWEON ; Yu-Il KIM ; In-Jae OH
Yonsei Medical Journal 2023;64(4):251-258
Purpose:
We aimed to identify factors influencing smoking cessation success among cancer patients registered in an inpatient smoking cessation program at a single cancer center.
Materials and Methods:
The electronic medical records of enrolled patients with solid cancer were retrospectively reviewed. We evaluated factors associated with 6-month smoking cessation.
Results:
A total of 458 patients with cancer were included in this study. Their mean age was 62.9±10.3 years, and 56.3% of the participants had lung cancer. 193 (42.1%) had not yet begun their main treatment. The mean number of counseling sessions for the participants was 8.4±3.5, and 46 (10.0%) patients were prescribed smoking cessation medications. The 6-month smoking cessation success rate was 48.0%. Multivariate analysis showed that younger age (<65 years), cohabited status, early stage, and the number of counseling sessions were statistically significant factors affecting 6-month smoking cessation success (p<0.05). Initiation of a cessation program before cancer treatment was significantly associated with cessation success (odds ratio, 1.66; 95% confidence interval, 1.02–2.70; p=0.040).
Conclusion
Smoking cessation intervention must be considered when establishing a treatment plan immediately after a cancer diagnosis among smokers.
4.Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation
Young Sook PARK ; Soo Hyung KIM ; Jong Won PARK ; Younglim KHO ; Pu Rum SEOK ; Jae-Ho SHIN ; Yoon Ji CHOI ; Jin-Hyun JUN ; Hee Chan JUNG ; Eun Kyung KIM
Intestinal Research 2020;18(3):325-336
Background/Aims:
Stress is closely related to the deterioration of digestive disease. Melatonin has potent anti-inflammatory properties. The objective of this study was to determine the effect of water stress (WS) and sleep deprivation (SD) on intestinal microbiota and roles of melatonin in stressful condition.
Methods:
We used C57BL/6 mice and specially designed water bath for stress and SD for 10 days. We measured melatonin concentrations in serum, feces, and colon tissues by high-performance liquid chromatography. Genomic DNA was extracted from feces and amplified using primers targeting V3 to V4 regions of bacterial 16S ribosomal RNA genes.
Results:
Compared to the control, melatonin concentration was lower in the WS and SD. Fecal concentration was 0.132 pg/mL in control, 0.062 pg/mL in WS, and 0.068 pg/mL in SD. In colon tissue, it was 0.45 pg/mL in control, 0.007 pg/mL in WS, and 0.03 pg/mL in SD. After melatonin treatment, melatonin concentrations in feces and colon tissue were recovered to the level of control. Metagenomic analysis of microbiota showed abundance in colitogenic microbiota in WS and SD. Melatonin injection attenuated this harmful effect. WS and SD showed decreased Lactobacillales and increased Erysipelotrichales and Enterobacteriales. Melatonin treatment increased Akkermansia muciniphila and Lactobacillus and decreased Bacteroides massiliensis and Erysipelotrichaceae.
Conclusions
This study showed that stress and SD could affect intestinal dysbiosis and increase colitogenic microbiota, which could contribute to the aggravating digestive disease. Melatonin concentrations in feces and colon tissue decreased under WS and SD. Melatonin treatment brought recovery of melatonin concentration in colon tissue and modulating dysbiosis of intestinal microbiota.